Xerox Holdings just released its Q3 2026 report, and the share price reacted immediately. The stock closed at US$1.47 after a 12% one-day slide heading into today, capping a rough three months for investors already dealing with sharp swings.
The headline issue is not weak demand; it is profit pressure. Xerox posted revenue of US$1.87b for the quarter but reported a net income loss of US$1.02b and paired that with a dividend suspension and a lower free cash flow outlook. Traders sold the stock on the news. The question now is whether that selling fully reflects the balance sheet strain that has just come into focus.
Concerned that Xerox Holdings just reported a quarterly loss along with balance sheet strain and a suspended dividend? If you want companies with sturdier finances, check out our list of solid balance sheet and fundamentals stocks (25 results)
Q3 2026 Earnings Summary
-
Revenue (Q3 2026 vs Q3 2025):US$1.87b vs. US$1.96b (top line declined about 5% year on year)
-
Net Income/Loss (Q3 2026 vs Q3 2025, excluding extra items):loss of US$1.02b vs. loss of US$764m (loss widened meaningfully year on year)
-
Basic EPS (Q3 2026 vs Q3 2025):loss of US$7.74 per share vs. loss of US$6.02 per share (per share loss increased year on year)
-
Adjusted Operating Margin (Q3 2026 vs Q3 2025):6.6% vs. 3.3% (adjusted profitability margin widened by 330 basis points year on year)
Ask Charlie what Xerox's dividend suspension signals about their balance sheet .
Xerox Bull Case Meets Mixed Operational Progress
Bulls argue that Lexmark integration will reset Xerox economics.
"The integration of Lexmark is creating a larger print platform and a higher synergy target of at least US$350 million. Management expects this to benefit adjusted operating income and support margin expansion over 2026 to 2028."
Early signs are visible. Adjusted operating margin widened to 6.6% as Print & Other trends improved and equipment revenue returned to growth. That is at least directionally consistent with the margin story. Yet the cut to full year adjusted operating income guidance, lower free cash flow outlook, and dividend suspension show that integration benefits are not yet offsetting cost inflation, weaker IT Solutions revenue, and the pressure from entry mix.
One Narrative disagrees with today's price. → See where this Narrative says Xerox Holdings should trade .
Xerox Bear Case: Execution Stumbles Move Front And Center
The skeptical view hinges on whether Xerox can turn promised restructuring into real, bankable profit.
"Although Lexmark integration synergies are now targeted at least at US$350 million through IT efficiencies, sourcing and shared services, realizing these benefits requires ongoing restructuring and integration work that already contributes to higher in-year restructuring charges."
The latest quarter leans toward the cautious side. Adjusted operating margin improved, yet full year adjusted operating income and free cash flow guidance were both cut. Dividend suspension, higher input costs, weaker IT Solutions revenue, and a delayed leverage timeline point to execution friction already flowing through reported results.
Hunt For Mispriced Earnings Stories
Xerox Holdings just reminded investors how quickly expectations can reset when profit pressure and balance sheet strain collide. The real opportunity could sit in companies where fundamentals and valuations still appear out of sync.
-
Company 1 - 46% below our estimate - helps large digital platforms route pay-ins and pay-outs across emerging markets as transaction volumes and product breadth expand.
-
Company 2 - 31% below our estimate - supplies connectivity, custom chips and software that keep rising data flows processed, secured and managed for the largest infrastructure buyers.
-
Company 3 - 48% below our estimate - co-designs complex hardware systems for medical, automotive and industrial clients that now want manufacturing partners embedded from concept through scaled production.
That is three of the list. See every one of the 29 undervalued companies on it →
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include XRX .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
